Page 16 - AIH-1-2
P. 16

Artificial Intelligence in Health                                         AI in the battle against COVID-19



            to combat infectious diseases. However, realizing this   Ethics approval and consent to participate
            potential will require thoughtful policy recommendations
            that promote innovation while addressing ethical, legal,   Not applicable.
            and social implications.                           Consent for publication
            12. Conclusion                                     Not applicable.

            The  COVID-19  pandemic  has  served as  a  catalyst  for   Availability of data
            unprecedented global change, particularly in the realms of
            healthcare and technology. AI has emerged as a critical tool   Not applicable.
            in combating the pandemic, offering solutions for detection,
            diagnosis, treatment, and management of the disease. In   References
            addition, it has played a significant role in understanding   1.   Marques ES, Moraes CL, Hasselmann MH, Deslandes SF,
            and predicting the spread of the virus, aiding in resource   Reichenheim ME. Violence against women, children, and
            allocation, and analyzing public sentiment.           adolescents during the COVID-19 pandemic: Overview,
                                                                  contributing factors, and mitigating measures.  Cad Saude
              Reflecting on the lessons learned, it becomes evident   Publica. 2020;36(4):e00074420.
            that AI holds the potential to transform public health      doi: 10.1590/0102-311X00074420
            responses  to  future pandemics. However, this  potential
            can only be realized through ethical practices, equitable   2.   Maital S, Barzani E. The global economic impact of
            access, and international collaboration. The integration of   COVID-19: A summary of research. Samuel Neaman Inst
            AI in healthcare demands a commitment to data privacy,   Nat Policy Res. 2020;2020:1-12.
            a focus on reducing algorithmic bias, and an emphasis   3.   Khan KS, Mamun MA, Griffiths MD, Ullah I. The mental
            on the creation of systems accessible to all, regardless of   health impact of the COVID-19 pandemic across different
            socioeconomic status.                                 cohorts. Int J Ment Health Addict. 2022;20:380-386.
              The case studies presented throughout this review highlight      doi: 10.1007/s11469-020-00367-0
            both the successes and failures of AI implementations   4.   Msemburi W, Karlinsky A, Knutson V, Aleshin-
            in various contexts, offering valuable insights for future   Guendel S, Chatterji S, Wakefield J. The WHO estimates of
            endeavors. Moving forward, emerging technologies such   excess mortality associated with the COVID-19 pandemic.
            as quantum computing, blockchain, and NGS will further   Nature. 2023;613:130-137.
            enhance the capabilities of AI in public health.      doi: 10.1038/s41586-022-05522-2
            Acknowledgments                                    5.   Assefa Y, Gilks CF, Pas R, Reid  S, Gete DG, Van
                                                                  Damme W. Reimagining global health systems for the
            None.                                                 21  century: lessons from the COVID-19 pandemic. BMJ
                                                                    st
                                                                  Glob Health. 2021;6:e004882.
            Funding
                                                                  doi: 10.1136/bmjgh-2021-004882
            This research was funded by Research on Quality Assurance
            and Evaluation of Higher Education in Jiangsu Province   6.   Vaishya R, Javaid M, Khan IH, Haleem A. Artificial
                                                                  intelligence (AI) applications for COVID-19 pandemic.
            under Grant No. 2023JSETKT032.                        Diabetes Metab Syndr Clin Res Rev. 2020;14:337-339.
            Conflict of interest                                  doi: 10.1016/j.dsx.2020.04.012

            The authors declare they have no competing interests.  7.   Darapaneni N, Sreevanth AT, Paduri AR, et al. Explainable
                                                                  Diagnosis, Lesion Segmentation and Quantification of
            Author contributions                                  COVID-19 Infection from CT Images using Convolutional
                                                                  Neural Networks. In:  2022 IEEE 13   Annual Information
                                                                                             th
            Conceptualization: Emma Yann Zhang, Adrian David      Technology, Electronics and Mobile Communication
               Cheok                                              Conference (IEMCON). IEEE; 2022. p. 171-178.
            Formal analysis: Emma Yann Zhang, Adrian David Cheok     doi: 10.1109/IEMCON53756.2022.9623045
            Investigation: Emma Yann Zhang, Adrian David Cheok
            Methodology: Emma Yann Zhang, Adrian David Cheok   8.   Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in
            Writing – original draft: Emma Yann Zhang, Adrian David   the diagnosis of COVID-19: Challenges and perspectives.
               Cheok                                              Int J Biol Sci. 2021;17:1581.
            Writing – review & editing: All authors               doi: 10.7150/ijbs.58855


            Volume 1 Issue 2 (2024)                         10                               doi: 10.36922/aih.2401
   11   12   13   14   15   16   17   18   19   20   21